Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 20/01/2008 Building of GATC Biotech AG in Konstanz

    LifeCodexx AG - Clarity within the genetic data jungle

    Constance based GATC Biotech founds the subsidiary company LifeCodexx AG. LifeCodexx is the first web-based information service for the storage and utilisation of biological and medical data from the analysis of genetic codes and protein codes in the EU.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/lifecodexx-ag-clarity-within-the-genetic-data-jungle
  • Article - 14/12/2016 Slow-Waves-EEG.jpg

    Transcranial brain stimulation to counteract chronic tiredness

    You may well be familiar with the ”leaden” feeling associated with lack of sleep. However, chronic tiredness lasting many months might be a sign of a serious disease. Dr. Lukas Frase, together with Prof. Dr. Christoph Nissen’s team at the Freiburg University Medical Center’s Department of Psychiatry and Psychotherapy, has come up with a method to help patients with abnormally high sleep needs. The method uses weak electrostimulation and has the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/transcranial-brain-stimulation-to-counteract-chronic-tiredness
  • Press release - 13/12/2016 A laboratory device being loaded with small reaction vessels.

    Early-diagnosis systems from Baden-Württemberg help prevent the spread of drug-resistant pathogens

    More and more bacteria are developing resistance to multiple antimicrobial drugs. These multidrug-resistant bacteria can impede the action of common antibiotics via mutations or DNA transfer. More than 30,000 people are infected every year with multidrug-resistant bacteria in German hospitals alone. This could be prevented with appropriate hygiene measures and innovative test systems. Innovative test systems that enable reliable and rapid…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/fruehdiagnostik-aus-baden-wuerttemberg-hilft-resistente-erreger-zu-stoppen
  • Article - 14/12/2009 10386_de.jpg

    Clever surveillance system keeps yeast in check

    The spectrum of human diseases (mycoses) caused by fungi ranges from trivial nail infections to life-threatening systemic infections. The latter are mainly caused by Candida albicans. The dermatologist Prof. Dr. med. Martin Schaller from Tübingen is investigating how this fungus, which is actually part of the normal microbial flora of humans, becomes a pathogen. At the same time, he is looking into the role the patient’s immune system plays in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/clever-surveillance-system-keeps-yeast-in-check
  • Article - 06/03/2011 13837_de.jpg

    Heidelberg Translational Lung Research Centre

    University and non-university research institutions in Heidelberg that carry out research into lung diseases have established an expert network – the Heidelberg Translational Lung Research Centre – which is part of the new BMBF-funded German Centre for Lung Research. In Heidelberg, research focuses on the development and treatment of cystic fibrosis, chronic obstructive pulmonary diseases and lung cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heidelberg-translational-lung-research-centre
  • Article - 10/02/2008

    The only professorship for preclinical imaging in Europe is in Tübingen

    The University of Tübingen opened its new laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens Foundation. The professorship is the only one in Europe combining preclinical imaging and the development of new imaging technologies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-only-professorship-for-preclinical-imaging-in-europe-is-in-tuebingen
  • Article - 03/03/2016 Schematic showing how liquid biopsies can be used to analyse freely circulating (fc) DNA in the blood. The schematic shows the technique as applied to GIST (gastrointestinal stroma tumours).

    Liquid biopsies – beacons of hope for cancer diagnosis?

    Researchers around the world, including researchers from the Freiburg University Medical Center, are working on developing simple blood tests, so-called liquid biopsies, that can be used to obtain accurate information about tumour staging and the progress of therapy. An international liquid biopsy symposium was held in Freiburg in October 2015 and has produced valuable insights.

    https://www.gesundheitsindustrie-bw.de/en/article/news/liquid-biopsies-beacons-of-hope-for-cancer-diagnosis
  • Press release - 15/11/2010 12969_de.png

    ASPEX- an advanced Schizosaccharomyces expression system

    The ASPEX system Asahi Glass Schizosaccharomyces Expression is a full-scale contract manufacturing service for recombinant proteins with up to the 3000 L scale. It is based on S. pombe an endotoxin-free fission yeast isolated from east African beer. Examples for gene expressions in the ASPEX system are manifold. The dedicated production facility located close to the Research Center is organized under cGMP rules and thus enables supply of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/aspex-an-advanced-schizosaccharomyces-expression-system
  • Article - 07/06/2008

    Gene mutations affect the chances of being cured of leukaemia

    Scientists at the University Hospital of Ulm and the Hanover Medical School MHH have succeeded in deciphering genetic defects in patients suffering from acute myeloid leukaemia. Their findings allow for more individualised therapies in the future.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gene-mutations-affect-the-chances-of-being-cured-of-leukaemia
  • Press release - 19/05/2020

    Cyber Valley welcomes five new members to its Start-Up Network

    Five new companies from the Stuttgart/Tübingen region in southwestern Germany have joined the Cyber Valley Start-Up Network. The innovative technologies and products of AmbiGate, Cytolytics, Mojin Robotics, plus10 and Tactai aim to achieve ground-breaking improvements in the fields of public health, manufacturing, and customer service. These start-ups join ten other companies that are already part of the Cyber Valley Start-Up Network.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cyber-valley-begruesst-fuenf-neue-mitglieder-seinem-start-network
  • Article - 21/07/2014 Schematic representation of multi-scale modelling: images of a molecule, cell, lung tissue and whole body, all connected with each other by arrows.<br />

    Predicting the efficiency of cancer drugs using mathematical models

    A research consortium was established at the Stuttgart Research Center Systems Biology SRCSB at the University of Stuttgart in January 2013 with the goal of establishing models that help predict the action of targeted therapeutics. The scientists combine molecular biology experiments with complex mathematical models in order to achieve a holistic understanding of disease and therapy.

    https://www.gesundheitsindustrie-bw.de/en/article/news/predicting-the-efficiency-of-cancer-drugs-using-mathematical-models
  • Article - 22/12/2014 Schematic showing T-cell activation without and without CTLA4.

    The immune system – both weak and overreactive in the absence of CTLA4

    The ability to recognise a pathogen and combat it effectively is certainly one of the most complex and sophisticated processes the human body has evolved. People with an immunodeficiency or autoimmune disease may have a genetic defect in one of the genes involved in the immune response. Working with immunologists from London scientists Desire Schubert and Prof. Dr. Bodo Grimbacher from the Centre for Chronic Immunodeficiency CCI at the Freiburg…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-immune-system-both-weak-and-overreactive-in-the-absence-of-ctla4
  • Article - 02/07/2008

    Virtual biopsy sharpens the view on fragile bones

    The X-ray-based determination of bone density is currently the only method that enables the early diagnosis of osteoporosis. However this examination method has rather limited informative value. That is why the University Hospital in Tübingen is now establishing high-resolution magnetic resonance imaging MRI that provides the physicians with completely new insights into the microarchitecture of the bones.

    https://www.gesundheitsindustrie-bw.de/en/article/news/virtual-biopsy-sharpens-the-view-on-fragile-bones
  • Dossier - 13/05/2013 19501_de.jpg

    The human proteome – the next major goal

    The “Human Proteome Project”, a ten-year global initiative that is making a systematic effort to map all human proteins, has moved from the planning to the experimental stage. How significant and how effective the project will be depends on how much the resources offered are used by proteome researchers and on the data that the researchers bring into the project.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-human-proteome-the-next-major-goal
  • Article - 05/06/2012 17261_de.jpg

    Max Planck Director Izaurralde honored for groundbreaking research

    Professor Dr. Elisa Izaurralde has made important contributions to the field of RNA biology in recent years. The managing director of the Max Planck Institute for Developmental Biology in Tübingen explores the complex mechanisms of cellular gene regulation. For her work on mRNA regulation she has now been honored with the prestigious Ernst Jung Prize for Medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/max-planck-director-izaurralde-honored-for-groundbreaking-research
  • Article - 19/01/2015 22608_de.jpg

    Kay Gottschalk and the physics of cells

    You learn a great deal about the physical aspects of cells when you talk to Prof. Dr. Kay-E. Gottschalk. For example, their ability to react as solid and liquid, to adapt their environment to suit themselves and to exert and respond to forces. The 42-year-old has great respect for the smallest of living units, i.e. cells, which he calls smart composite materials. Working on the boundaries of medicine, biology, chemistry and physics, Gottschalk…

    https://www.gesundheitsindustrie-bw.de/en/article/news/kay-gottschalk-and-the-physics-of-cells
  • Article - 12/06/2017 Photo shows of man (left) being withdrawn blood. The blood flows through a tube from the cannula to the blood collection tube.

    IHO: global consulting for the molecular diagnosis of leukaemia

    IHO GmbH from Mannheim offers a professional solution for the international exchange of information and services concerning the molecular diagnosis of leukaemia. This drives forward the harmonisation of these methods and brings therapy monitoring to a new global level.

    https://www.gesundheitsindustrie-bw.de/en/article/news/iho-global-consulting-for-the-molecular-diagnosis-of-leukaemia
  • Press release - 19/01/2011

    Colonoscopy Provides Protection from Cancer on Both Sides of the Colon

    Scientists of the German Cancer Research Center DKFZ in Heidelberg have now shown that inspection of both sides of the colon also reduces cancer risk in the right part of the colon by more than 50 percent. The overall risk was found to be 77 percent lower. This means that colonoscopy provides very good protection from colon cancer - even though it is not a 100 percent guarantee.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/colonoscopy-provides-protection-from-cancer-on-both-sides-of-the-colon
  • Press release - 01/06/2011 14443_de.jpg

    Heidelberg expert to coordinate European network on inherited metabolic disorders

    A European network for research into rare inherited metabolic disorders will be coordinated by PD Dr. Stefan Kölker, head of the Division of Inherited Metabolic Diseases at the Centre for Paediatric and Adolescent Medicine, University of Heidelberg. The project, which will initially run for three years, has a financial volume of 1.3 million euros. More than 40 partners from 17 European countries are part of the “European registry and network for…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-expert-to-coordinate-european-network-on-inherited-metabolic-disorders
  • Press release - 24/02/2021

    Supposedly "silent" mutation with serious consequences

    So-called silent mutations have no effect on the composition of a protein. They are therefore not considered to promote cancer. However, scientists from the German Consortium for Translational Cancer Research (DKTK), partner site Essen, now describe in a case of kidney cancer an overlooked silent mutation with a major impact on prognosis.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/supposedly-silent-mutation-serious-consequences
  • Article - 31/03/2008

    "Nanomedicine will be able to combat incurable diseases"

    The first European Conference for Clinical Nanomedicine is to be held soon in Basel. BIOPRO has therefore discussed this promising area of application with Beat Löffler and Dr. Patrick Hunziker the founders of the European Foundation for Clinical Nanomedicine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/nanomedicine-will-be-able-to-combat-incurable-diseases
  • Press release - 17/11/2022

    MEDICA and COMPAMED present themselves as extremely vital platforms in turbulent times

    MEDICA and COMPAMED continue to develop in an extremely vital manner. The world's leading medical trade fair and the international No. 1 for the medical technology supply sector once again impressively underscored their positive results from the previous year with strong numbers – despite continuing adverse conditions. A significant increase in bookings on the part of the exhibiting companies was followed after four days by a marked increase…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/medica-und-compamed-praesentieren-sich-als-aeusserst-vitale-plattformen-bewegten-zeiten
  • Press release - 22/06/2009 Logo of BioRN

    Successful start: cooperative projects of the Rhine-Neckar Biotechnology Cluster (BioRN)

    The first joint public appearance of the numerous players of the BioRN top cluster underlines the importance of cooperations between industry and science. At the first annual BioRN conference the Cell-based and molecular medicine top cluster announced the successful start of five cooperative projects funded by the German Federal Ministry of Education and Research. In a strategy workshop the companies involved in the projects presented all 36…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-start-cooperative-projects-of-the-rhine-neckar-biotechnology-cluster-biorn
  • Press release - 23/07/2020

    Images from the inside of blood vessels

    Smallest 3D printed miniature endoscope in the world detects cholesterol plaques and thrombs inside human and mouse arteries.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-bilder-aus-dem-inneren-von-adern
  • Article - 14/08/2018 Photo of the developer team (from left to right): Jonas Pfeil, Daniel
Geiger and Tobias Neckernuß. An optical measurement system can be seen on the right-hand side. Photo: Daniel Geiger

    Simple and fast: new optical method for analysing living cells

    The junior researchers Dr. Daniel Geiger, Tobias Neckernuß and Jonas Pfeil from Ulm have developed an innovative method for non-contact real-time analysis of cells and other particles. The analysis involves low data rates and correspondingly little effort. This is what makes the method so attractive for medical applications.

    https://www.gesundheitsindustrie-bw.de/en/article/news/simple-and-fast-new-optical-method-for-analysing-living-cells

Page 13 / 17

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search